Azapropazone pp 255-263 | Cite as

Serious gastrointestinal reactions to azapropazone: an estimate of the risk

  • B. Simon
  • J. F. Hort

Abstract

It would be ideal if physicians could be told precisely what the chance was of a serious gastrointestinal reaction a particular patient would experience from taking any particular non-steroidal anti-inflammatory drug (NSAID). At present this is not possible but enough data do exist to provide at least some estimate for azapropazone. These data derive from three sources: National Regulatory Authorities, large post-marketing surveillance studies and from clinical trials.

Keywords

Duodenal Ulcer Define Daily Dose Yellow Card Adverse Drug Reaction Advisory Committee National Regulatory Authority 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mann, RD (ed.) (1987). Adverse Drug Reactions (Parthenon: Carnforth (UK) and Park Ridge (USA)) pp. 36–46Google Scholar
  2. 2.
    Rainsford, KD and Velo, GP (eds.) (1987). New Developments in Antirheumatic Drugs. (Lancaster: MTP Press) pp. 55–70Google Scholar
  3. 3.
    Faust-Tinnefeldt, G (1977). Wirkung von Azapropazon auf den Gastrointesti-naltrakt und die Leber. Therapiewoche, 28, 8567–8574Google Scholar
  4. 4.
    Brooks, PM and Buchanan, WW (1976). Azapropazone, its place in the management of rheumatoid conditions. Curr Med Res Opin, 4, 94–100PubMedCrossRefGoogle Scholar
  5. 5.
    Capell, HA, McLeod, MM, Hernandez, LA, Grennan, DM and Templeton, JS (1976). Comparison of azapropazone and naproxen in rheumatoid arthritis. Curr Med Res Opin, 4, 285–289PubMedCrossRefGoogle Scholar
  6. 6.
    Hicklin, JA, Hingorani, K, Lloyd, KN, Templeton, JS and Wilkinson, M (1976). Azapropazone compared with indomethacin in the treatment of rheumatoid arthritis. Practitioner, 217, 3–7Google Scholar
  7. 7.
    Hingorani, K and Templeton, JS (1975). A comparative trial of azapropazone and ketoprofen in the treatment of acute backache. Curr Med Res Opin, 3, 407–412PubMedCrossRefGoogle Scholar
  8. 8.
    Kean, WF, Kraag, GR, Rooney, PJ and Capell, HA (1981). Clinical therapeutic trial of aspirin and azapropazone in rheumatoid arthritis when prescribed singly and in combination. Curr Med Res Opin, 7, 164–167PubMedCrossRefGoogle Scholar
  9. 9.
    Panayi, XIth European Congress of Rheumatology, Athens, 1987Google Scholar
  10. 10.
    Frank, AJM, Moll, JMN and Hort, JF (1982). A comparison of three ways of measuring pain. Rheumatol Rehab, 21, 211–217CrossRefGoogle Scholar
  11. 11.
    Grennan, DM, McLeod, M, Watkins, C and Dick, WC (1976). Clincial assessment of azapropazone in rheumatoid arthritis. Curr Med Res Opin, 4, 44–49PubMedCrossRefGoogle Scholar
  12. 12.
    Lassus, A. (1976). A comparative pilot study of azapropazone and indomethacin in the treatment of psoriatic arthritis and Reiter’s disease. Curr Med Res Opin, 4, 65–69PubMedCrossRefGoogle Scholar
  13. 13.
    Thune, SA (1976). A comparative study of azapropazone and indomethacin in the treatment of rheumatoid arthritis. Curr Med Res Opin, 4, 70–75PubMedCrossRefGoogle Scholar
  14. 14.
    Robins, AH. Data on file (1984)Google Scholar
  15. 15.
    Berry, H, Bloom, B, Mace, BEW, Hamilton, EBD, Fernandes, L, Molloy, M and Williams, IA (1980). Expectation and patient preference - does it matter? J Roy Soc Med, 73, 34–38PubMedGoogle Scholar
  16. 16.
    Kamal, A (1983). Azapropazone in elderly patients. Br J Rheumatol (letter)Google Scholar
  17. 17.
    Robins, AH. Data on file (1988)Google Scholar
  18. 18.
    Rooney, M. Xlth European Congress of Rheumatology, Athens, 1987Google Scholar
  19. 19.
    Calcraft, B, Tildesley, G, Evans, KT, Gravelle, H, Hole, D and Lloyd, KN (1974). Azapropazone in the treatment of ankylosing spondylitis: A controlled clinical trial. Rheumatol Rehab, 13, 23–29CrossRefGoogle Scholar
  20. 20.
    Robins, AH. Data on file (1987)Google Scholar
  21. 21.
    Robins, AH. Data on file (1978)Google Scholar
  22. 22.
    Wheatley, D (1984). Azapropazone in arthritis: a long-term treatment. Curr Med Res Opin, 9, 86–92PubMedCrossRefGoogle Scholar
  23. 23.
    Eberl, R (1976). Prolonged treatment with azapropazone. Curr Med Res Opin, 4, 76–79PubMedCrossRefGoogle Scholar
  24. 24.
    Fraser, RC, Davis, RH and Walker, FS (1987). Comparative trial of azapropazone and indomethacin plus allopurinol in acute gout and hyperuricaemia. J Roy Coll Gen Practit, September 1987, 409–411Google Scholar
  25. 25.
    Rainsford, KD (1982). An analysis of the gastro-intestinal side effects of nonsteroidal anti-inflammatory drugs, with particular reference to comparative studies in man and laboratory species. Rheumatol Int, 2, 1–10PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • B. Simon
  • J. F. Hort

There are no affiliations available

Personalised recommendations